FDA Grants Fast Track Status to VS-041, a Novel MM...
Category : ODD/BTA/FTA Status 19 November 2025Vasa Therapeutics has received FDA Fast Track designation for VS-041, its lead investigational small...
Odd Bta Fta Status
FDA Grants Orphan Drug Designation to Calico and A...
Category : ODD/BTA/FTA Status 6 November 2025California, October 2025: Calico Life Sciences LLC (Calico), a biotechnology company founded by Alph...
Halia Therapeutics Receives FDA Orphan Drug Design...
Category : ODD/BTA/FTA Status 25 October 2025Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on therapies that targe...
FDA Grants Fast Track Designation to AnnJi’s AJ201...
Category : ODD/BTA/FTA Status 24 October 2025AnnJi Pharmaceutical Co., Ltd. (TWSE: 7754) announced that the U.S. Food and Drug Administration (FD...
Cidara Therapeutics’ CD388 Receives FDA Breakthrou...
Category : ODD/BTA/FTA Status 13 October 2025Cidara Therapeutics announced that the U.S. FDA has granted Breakthrough Therapy designation for CD3...
Latest Newsletter Post
-
FDA Grants Fast Track Status to VS-..
19 November 2025
-
Mycovia’s VIVJOA Shows Sustained 96..
19 November 2025
-
Creatine HCl Shows Promise for Meno..
19 November 2025
-
Merck’s Winrevair Shows Promise in..
19 November 2025
-
TransCon CNP Shows Promising Week 5..
18 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com